Related Experiment Video
Updated: Sep 27, 2026

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular
Hidemi Ishii1, Tsuyoshi Tezuka, Hiroyuki Ishikawa
1Department of Public Health, Showa Pharmaceutical University, Machida, Tokyo, Japan. h-ishii@ac.shoyaku.ac.jp
Abstract:
The present work investigated the mechanism for down-regulation of thrombomodulin (TM), an anticoagulant glycoprotein, on cultured umbilical vein endothelial cells (HUVECs) exposed to lipid extracts from oxidized low-density lipoprotein (ox-LDL). HUVECs exposed to phospholipid extracts, but not to free cholesterol, triglyceride, or cholesterol ester, isolated from ox-LDL reduced TM mRNA levels to nearly the same extent as native ox-LDL. Oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine (ox-PAPC), but not native PAPC or a reduced form of ox-PAPC, markedly decreased TM mRNA levels. The apparent half-life (t 1/2 = 2.7 hours) of TM mRNA in control cells was not significantly different from that in cells exposed to ox-LDL or ox-PAPC. TM mRNA levels were regulated by transcriptional activation via a retinoid receptor beta (RARbeta). The binding activities of nuclear proteins from HUVECs treated with ox-LDL or ox-PAPC to the DR4 or stimulatory protein 1 (Sp1) sequence in the TM promoter were significantly reduced with decreased expression of RARbeta, retinoid X receptor alpha (RXRalpha), Sp1, and Sp3 in the nuclei. The promoter activity in HUVECs transfected with a reporter plasmid expressing the TM promoter with targeted deletions in the DR4 and Sp1 binding elements was decreased to about 20% of that with the wild-type construct. Treatment of the cells with ox-PAPC had no additional effect on the promoter activity. These results suggest that oxidized phospholipids in ox-LDL inhibit transcription of the TM gene in HUVECs by inhibiting the binding of RARbeta-RXRalpha heterodimer and Sp, including Sp1 and Sp3, to the DR4 element and Sp1 binding element, respectively, in the TM promoter with reduced expression of RARbeta, RXRalpha, and Sp1 and Sp3 in the nuclei.
Insights
Oxidized phospholipids in oxidized low-density lipoprotein (ox-LDL) reduce thrombomodulin (TM) gene transcription in endothelial cells. This occurs by inhibiting key protein binding to the TM promoter, decreasing TM expression.
Area of Science:
- Biochemistry
- Molecular Biology
- Endothelial Cell Biology
Background:
- Thrombomodulin (TM) is an anticoagulant glycoprotein crucial for vascular health.
- Oxidized low-density lipoprotein (ox-LDL) is implicated in atherosclerosis and endothelial dysfunction.
- The precise mechanisms by which ox-LDL affects TM expression are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms underlying TM gene down-regulation by ox-LDL in human umbilical vein endothelial cells (HUVECs).
- To identify the specific components of ox-LDL responsible for TM down-regulation.
- To elucidate the role of transcription factors and promoter elements in this process.
Main Methods:
- Cultured HUVECs were treated with lipid extracts from ox-LDL and specific oxidized phospholipids like oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine (ox-PAPC).
- TM mRNA levels and stability were assessed.
- Nuclear protein binding activity to TM promoter sequences (DR4, Sp1) was measured using electrophoretic mobility shift assays.
- Reporter gene assays were performed with TM promoter constructs.
- Expression levels of key transcription factors (RARbeta, RXRalpha, Sp1, Sp3) were analyzed.
Main Results:
- Phospholipid components of ox-LDL, particularly ox-PAPC, significantly reduced TM mRNA levels in HUVECs.
- TM mRNA stability was not affected, indicating transcriptional regulation.
- Ox-LDL and ox-PAPC treatment decreased the binding of nuclear proteins to the DR4 and Sp1 elements in the TM promoter.
- This decrease correlated with reduced expression of RARbeta, RXRalpha, Sp1, and Sp3.
- Reporter assays confirmed the importance of DR4 and Sp1 binding sites for TM promoter activity.
Conclusions:
- Oxidized phospholipids within ox-LDL inhibit TM gene transcription in HUVECs.
- This inhibition is mediated by reduced binding of RARbeta-RXRalpha heterodimers and Sp proteins (Sp1, Sp3) to the TM promoter.
- Reduced expression of these transcription factors contributes to the down-regulation of TM expression, potentially impacting endothelial anticoagulant function.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Master Transcription Regulators
